PIERANTONI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 750
AS - Asia 727
EU - Europa 369
SA - Sud America 134
AF - Africa 117
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 13
Totale 2.131
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 675
SG - Singapore 285
IT - Italia 122
CN - Cina 103
VN - Vietnam 100
BR - Brasile 82
HK - Hong Kong 66
BD - Bangladesh 32
DE - Germania 31
FR - Francia 25
IN - India 24
GB - Regno Unito 22
NL - Olanda 20
PL - Polonia 17
CA - Canada 16
RU - Federazione Russa 14
IQ - Iraq 13
FI - Finlandia 11
AT - Austria 9
GF - Guiana Francese 9
JP - Giappone 9
EC - Ecuador 8
RS - Serbia 8
TR - Turchia 8
CZ - Repubblica Ceca 7
ET - Etiopia 7
ZA - Sudafrica 7
AL - Albania 6
AO - Angola 6
AR - Argentina 6
DO - Repubblica Dominicana 6
ES - Italia 6
GH - Ghana 6
KR - Corea 6
PE - Perù 6
SA - Arabia Saudita 6
SE - Svezia 6
UA - Ucraina 6
YT - Mayotte 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
BW - Botswana 5
CG - Congo 5
CL - Cile 5
CO - Colombia 5
GE - Georgia 5
GT - Guatemala 5
HU - Ungheria 5
JO - Giordania 5
KE - Kenya 5
LC - Santa Lucia 5
NP - Nepal 5
NZ - Nuova Zelanda 5
PA - Panama 5
PK - Pakistan 5
PT - Portogallo 5
PY - Paraguay 5
SK - Slovacchia (Repubblica Slovacca) 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
BF - Burkina Faso 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
CR - Costa Rica 4
GA - Gabon 4
HT - Haiti 4
ID - Indonesia 4
MN - Mongolia 4
MX - Messico 4
MY - Malesia 4
NO - Norvegia 4
ZM - Zambia 4
AD - Andorra 3
BZ - Belize 3
CD - Congo 3
CM - Camerun 3
DJ - Gibuti 3
GN - Guinea 3
GR - Grecia 3
HR - Croazia 3
IE - Irlanda 3
IR - Iran 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LB - Libano 3
MA - Marocco 3
ML - Mali 3
NE - Niger 3
PH - Filippine 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SO - Somalia 3
SV - El Salvador 3
TH - Thailandia 3
TL - Timor Orientale 3
TZ - Tanzania 3
VC - Saint Vincent e Grenadine 3
VE - Venezuela 3
XK - ???statistics.table.value.countryCode.XK??? 3
AU - Australia 2
Totale 2.038
Salva come PNG Salva come JPEG
Città #
Singapore 192
Ashburn 174
San Jose 142
Santa Clara 60
Hong Kong 58
Ho Chi Minh City 32
Hanoi 25
Council Bluffs 21
New York 21
Los Angeles 15
Munich 15
Boardman 14
Lauterbourg 14
Orem 13
São Paulo 12
Beijing 11
Hefei 10
Milan 10
Rome 10
Tokyo 9
Buffalo 8
Bytom 8
Chennai 8
Accra 6
Atlanta 6
Brooklyn 6
Denver 6
Fairfield 6
Haiphong 6
Hải Dương 6
Montreal 6
Redondo Beach 6
Sesto San Giovanni 6
Amman 5
Castries 5
Cayenne 5
Da Nang 5
Johannesburg 5
Luanda 5
Nairobi 5
Naples 5
Padova 5
Panama City 5
Turku 5
Vienna 5
Warsaw 5
Abidjan 4
Addis Ababa 4
Auckland 4
Belgrade 4
Calcinato 4
Cambridge 4
Chicago 4
Falkenstein 4
Jeddah 4
Lappeenranta 4
Libreville 4
Lusaka 4
Manchester 4
New Delhi 4
Nuremberg 4
Port-au-Prince 4
Porto Alegre 4
Tbilisi 4
Tianjin 4
Ulan Bator 4
Amsterdam 3
Andorra la Vella 3
Bamako 3
Beirut 3
Bishkek 3
Biên Hòa 3
Budapest 3
Bến Tre 3
Chengdu 3
Ciudad del Este 3
Conakry 3
Cosenza 3
Dallas 3
Dublin 3
Frankfurt am Main 3
Genoa 3
Guayaquil 3
Kingstown 3
Kinshasa 3
Kuala Lumpur 3
London 3
Maitengwe 3
Miami 3
Minsk 3
Palermo 3
Paris 3
Pelotas 3
Poplar 3
Prague 3
Pristina 3
San Diego 3
San Salvador 3
Santo Domingo 3
Seoul 3
Totale 1.189
Salva come PNG Salva come JPEG
Nome #
Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical Parameters 234
Advanced Non-Clear Cell Renal Cell Carcinoma Treatments and Survival: A Real-World Single-Centre Experience 168
Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: technical aspects and primary staging setting 156
The prognostic Value of Thyroid Hormone Levels in Immunotherapy-Treated Patients With Metastatic Urothelial Carcinoma 156
Clinical relevance of molecular biomarkers in urothelial carcinomas treated with chemotherapy, immunotherapy or targeted-therapies 151
Patient Reported Outcomes, Paternity, Relationship, and Fertility in Testicular Cancer Survivors: Results from a Prospective Observational Single Institution Trial 140
Prognostic role of systemic inflammation indexes in metastatic urothelial carcinoma treated with immunotherapy 134
Nivolumab drug holiday in patients treated for metastatic renal cell carcinoma: A real-world, single-centre experience 133
Immune checkpoint inhibitors rechallenge in urological tumors: An extensive review of the literature 131
Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial 129
Real-World Treatment with Nivolumab or Cabozantinib for Metastatic Renal Cell Carcinoma (mRCC) in the Veneto Region of Italy: Results of AMOUR Study 127
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations 124
Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study 122
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a) 120
Comprehensive geriatric assessment is an independent prognostic factor in older patients with metastatic renal cell cancer treated with first-line Sunitinib or Pazopanib: a single center experience 106
Totale 2.131
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.535
article - articoli 6.227
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.762
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202218 0 1 0 0 1 8 1 0 0 2 1 4
2022/20233 2 0 0 0 0 1 0 0 0 0 0 0
2023/202458 0 1 1 2 15 11 0 6 3 0 5 14
2024/2025439 0 66 14 18 41 25 10 54 4 14 57 136
2025/20261.560 80 85 198 158 175 84 224 145 166 85 112 48
2026/202741 34 7 0 0 0 0 0 0 0 0 0 0
Totale 2.131